BRIEF-Helix Biopharma announces deal with National Research Council of Canada
July 18 (Reuters) - Helix Biopharma Corp
* Helix Biopharma announces agreement in principle with National Research Council of Canada to collaborate on various immuno-oncology initiatives
* Agreement spells out framework to enable Helix to finalize master agreement with NRC to develop new therapeutics for cancer immunotherapies
* Agreement allows for discussion on a potential license of antibody previously obtained from NRC under a material transfer agreement Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.